Who is the CEO of Epi Biotech?

According to the DART company overview, Epi Biotech's representative director is 성종혁 (name as registered in Korean). The company was founded on 2015-12-23.

Where is Epi Biotech listed?

Epi Biotech trades on the Korea Exchange KONEX market under the ticker 446440. Its fiscal year ends in December.

Does Epi Biotech pay a dividend?

Epi Biotech did not pay a cash dividend for fiscal 2025, according to its annual report.

Which companies are in the same industry as Epi Biotech?

Under the Korean Standard Industrial Classification recorded on DART, Epi Biotech is grouped with 52 other listed companies in medical & pharmaceutical r&d. The most covered in Korean news over the past 30 days are Alteogen, Qurient and Vaxcell-Bio Therapeutics.

Epi Biotech KRX:446440KONEX

에피바이오텍 · Korean news coverage and regulatory filings, organized.

한국어

Articles, 24h0

Articles, 7 days0

DART filings, 7 days0

Articles tracked0since Sep 11

Epi Biotech (에피바이오텍) appeared in 0 Korean news articles and 0 DART filings over the past seven days.

Epi Biotech top stories 2 weeks, by number of outlets

No story covered by multiple outlets in the past two weeks.

Latest Epi Biotech news Korean headlines

No articles yet.

Articles per day 2 weeks

Company profile

CEO: 성종혁
Industry: Medical & pharmaceutical R&D
Founded: 2015-12-23
Fiscal year-end: December
Head office: 인천광역시 연수구
Website: epibiotech.com
Quotes & chart: Naver Securities (Korean)

From the DART company overview.

Same industry Medical & pharmaceutical R&D

All in industry

Company	Latest quarter op. profit	Articles 30d
Alteogen	₩34.2bn	55
Qurient	−₩12.8bn	26
Vaxcell-Bio Therapeutics	−₩5.0bn	22
OliX Pharmaceuticals	−₩14.0bn	20
Penetrium Bioscience	−₩1.9bn	19
Aribiolab	−₩2.5bn	15
LigaChem Biosciences	−₩72.0bn	14
ImmuneOncia Therapeutics	−₩4.3bn	14

Compare Epi Biotech side by side with these companies

Epi Biotech DART filings

Sep 1716:13

Investor relations event 기업설명회(IR)개최
Other

Mentioned alongside 2 weeks

No co-mentioned companies yet.

Epi Biotech FAQ

Who is the CEO of Epi Biotech?: According to the DART company overview, Epi Biotech's representative director is 성종혁 (name as registered in Korean). The company was founded on 2015-12-23.
Where is Epi Biotech listed?: Epi Biotech trades on the Korea Exchange KONEX market under the ticker 446440. Its fiscal year ends in December.
Does Epi Biotech pay a dividend?: Epi Biotech did not pay a cash dividend for fiscal 2025, according to its annual report.
Which companies are in the same industry as Epi Biotech?: Under the Korean Standard Industrial Classification recorded on DART, Epi Biotech is grouped with 52 other listed companies in medical & pharmaceutical r&d. The most covered in Korean news over the past 30 days are Alteogen, Qurient and Vaxcell-Bio Therapeutics.